jardiance Coupons 2018

Empagliflozin
10mg / 25mg
6%
OFF
Drug Store Discounter
Drug Store Discounter
drugstore-discounter.com
promo code neo6
7%
OFF
RS of GM
RS of GM
generics-supplier.com
promo code off7now
6%
OFF
Online Pharmacy US
Online Pharmacy US
online-pharmacy-us.com
promo code wcoqd
5%
OFF
meRXnow
meRXnow
merxnow.com
promo code fpwb88g
8%
OFF
Trusted Pharmacy 4U
Trusted Pharmacy 4U
trustedpharm4u.com
promo code 4u2018

no insurance

Jardiance Coupon 2018

Jardiance (empagliflozin / empagliflozin) is an anti-diabetic drug. It is produced by pharmaceutical companies “Boehringer Ingelheim” and “Eli Lilly”. The US drug stores began selling the drug Jardiance. The drug Jardiance is a prescription drug, so it is a pharmaceutical drug that requires a medical prescription to be dispensed. It is intended for the treatment of type 2 diabetes. The drug received the approval of The Food & Drug Administration (FDA) in the dosages of 10 mg and 25 mg for the use in the combination with a diet and exercise to improve glycemic control among adult patients.

The drug Jardiance (empagliflozin) is a selective inhibitor of sodium-dependent glucose transporter 2, the action of which is intended to block the reabsorption of glucose in the kidneys, and that leads to the excretion of glucose and lowers glucose levels in the blood.

The drug Jardiance is contraindicated to the patients with type 1 diabetes or the patients with diabetic ketoacidosis. It is not recommended to prescribe the drug to the patients with chronic kidney disease or dialysis-dependent patients. The drug Jardiance is also contraindicated to the patients, who are sensitive to empagliflozin or the other components of the drug.

The result of Phase III clinical trials became the basis for the approval of the drug Jardiance. The clinical program included more than ten international trials. The clinical trials involved more than 13,000 adult patients suffering from type 2 diabetes mellitus. As a result of the trials it was established, that those patients with diabetes mellitus, who was taking empagliflozin without any additional drugs or in a combination with other anti-diabetic drugs (metformin, sulfonylurea, insulin, pioglitazone), had a reduction of glycosylated hemoglobin and blood sugar among the patients.